Hubei Jumpcan Pharmaceutical Co Ltd

SSE:600566

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hubei Jumpcan Pharmaceutical Co Ltd's stock price target?

Price Target

53.41 CNY

According to Wall Street analysts, the average 1-year price target for Hubei Jumpcan Pharmaceutical Co Ltd is 53.41 CNY with a low forecast of 52.88 CNY and a high forecast of 54.98 CNY.

What is Hubei Jumpcan Pharmaceutical Co Ltd's Revenue forecast?

Projected CAGR

10%

For the last 8 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's revenue is 15%. The projected CAGR for the next 3 years is 10%.

What is Hubei Jumpcan Pharmaceutical Co Ltd's Operating Income forecast?

Projected CAGR

16%

For the last 8 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's operating income is 19%. The projected CAGR for the next 4 years is 16%.

What is Hubei Jumpcan Pharmaceutical Co Ltd's Net Income forecast?

Projected CAGR

15%

For the last 8 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's net income is 20%. The projected CAGR for the next 3 years is 15%.